Clinical Trial Update: A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a phase 2 study evaluating the combination of rucaparib and nivolumab in people with leiomyosarcoma, with the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma

Drugs mentioned

• OPDIVO (nivolumab)
• RUBRACA (RUCAPARIB)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leiomyosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING